Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
<p>Objective: To measure the placebo-controlled effects of combination therapy on hypotension, treatment discontinuation and major renal outcomes, according to baseline blood pressure.</p> <p>Methods: We conducted an analysis of the ADVANCE and PROGRESS trials, including 14,684 par...
Hoofdauteurs: | Atkins, A, Hirakawa, Y, Salam, A, Woodward, M, Cooper, M, Hamet, P, Harrap, S, Lees, K, Lisheng, L, Mancia, G, Marre, M, Perkovic, V, Poulter, N, Williams, B, Chalmers, J, Rodgers, A |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Lippincott, Williams & Wilkins
2017
|
Gelijkaardige items
-
Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
door: Rahman, F, et al.
Gepubliceerd in: (2019) -
Lowering blood pressure reduces renal events in type 2 diabetes.
door: de Galan, B, et al.
Gepubliceerd in: (2009) -
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
door: Czernichow, S, et al.
Gepubliceerd in: (2011) -
Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
door: Kengne, A, et al.
Gepubliceerd in: (2009) -
Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis.
door: Hirakawa, Y, et al.
Gepubliceerd in: (2017)